BioNTech Eyes Construction Start for African Vaccine Factory in Mid-2022

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
TT

BioNTech Eyes Construction Start for African Vaccine Factory in Mid-2022

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic
Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic

Germany's BioNTech, which developed a coronavirus jab with US pharmaceutical giant Pfizer, said Tuesday it aims to begin building a vaccine plant in Africa next year.

The project is expected to address the continent's shortage of COVID-19 vaccines and boost its flagging vaccination drive, with only 5.2 percent of its population fully inoculated, according to the Africa CDC.

BioNTech said it was working with authorities in both Rwanda and Senegal and plans to begin construction "in mid-2022".

The plant will initially have capacity to produce around 50 million vaccine doses per year, the German company said.

BioNTech had in August announced plans to build "sustainable vaccine production capabilities" in Rwanda and Senegal, producing not only COVID-19 vaccines but also mRNA-based malaria and tuberculosis vaccines.

“Together, we will work on developing a regional manufacturing network to support the access to vaccines manufactured in Africa, for Africa,” Chief Executive of BioNTech Ugur Sahin said.

In July, Pfizer and BioNTech announced that they were partnering with the Biovac Group to bottle their COVID-19 vaccine in Cape Town, South Africa, beginning in 2022.

However, the creation of the messenger RNA—the most delicate and crucial step—will continue to be carried out in Europe.

Currently, just one percent of vaccines used in Africa are manufactured on the continent. The African Union wants to increase this proportion to 60 percent by 2040.

US pharmaceutical giant Moderna earlier this month also announced plans to build a vaccine plant in Africa.

Africa, home to 1.2 billion people, is the least vaccinated continent in the world.

Test tubes are seen in front of a displayed Biontech logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic



Erdogan Ally Floats Türkiye Constitutional Amendment to Let Him Extend His Tenure

Türkiye’s President and leader of Justice and Development (AK) Party Recep Tayyip Erdogan attends an election campaign rally in Istanbul on March 24, 2024, ahead of the March 31 municipal elections. (AFP)
Türkiye’s President and leader of Justice and Development (AK) Party Recep Tayyip Erdogan attends an election campaign rally in Istanbul on March 24, 2024, ahead of the March 31 municipal elections. (AFP)
TT

Erdogan Ally Floats Türkiye Constitutional Amendment to Let Him Extend His Tenure

Türkiye’s President and leader of Justice and Development (AK) Party Recep Tayyip Erdogan attends an election campaign rally in Istanbul on March 24, 2024, ahead of the March 31 municipal elections. (AFP)
Türkiye’s President and leader of Justice and Development (AK) Party Recep Tayyip Erdogan attends an election campaign rally in Istanbul on March 24, 2024, ahead of the March 31 municipal elections. (AFP)

The main political ally of longstanding Turkish leader Recep Tayyip Erdogan said on Tuesday that a constitutional amendment should be considered to allow the president to run again in elections set for 2028.

After his re-election last year, Erdogan is serving his last term as president unless parliament calls an early election, according to the constitution. He has ruled Türkiye for more than 21 years, first as prime minister and then as president.

"Wouldn't it be a natural and right choice to have our president elected once again if terror is eradicated, and if a heavy blow is dealt to inflation and Türkiye secures political and economic stability," said Devlet Bahceli, leader of the Nationalist Movement Party (MHP), which is allied with Erdogan's ruling AK Party (AKP).

A constitutional amendment to secure Erdogan's ability to re-run in the presidential elections should be considered, he said in a parliamentary speech to MHP lawmakers.

Bahceli, a staunch nationalist, rattled Turkish politics last month by suggesting that the jailed leader of the outlawed Kurdistan Workers' Party (PKK) could be allowed to speak in parliament if he announces an end to the group's insurgency.

Some analysts said the shock suggestion might be motivated by an AKP-MHP desire to win the support of the pro-Kurdish DEM Party, parliament's third-biggest, for a constitutional change that could boost Erdogan's prospects in 2028 elections.

A constitutional change can be put to a referendum if 360 lawmakers in the 600-seat parliament back it. An early election also needs the support of 360 MPs.

AKP and its allies have 321 seats while DEM has 57.